All Outputs (2)

A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid. (2024)
Presentation / Conference
STOIBER, A., GRAY, G., SAILER, G., HUF, W. and TONNA, A. 2024. A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid. Poster presented at the 28th European Association of Hospital Pharmacists (EAHP) annual congress 2024 (EAHP 2024): sustainable healthcare; opportunities and strategies, 20-22 March 2024, Bordeaux, France.

Paxlovid ®, the only orally available COVID drug, consists of two main components: Nirmatrelvir and Ritonavir. Ritonavir is known for the potent inhibition of CYP (cytochrome P450) enzymes in the liver mainly of CYP3A4, resulting in a large number of... Read More about A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid..

Antimicrobial stewardship: a potential role for pharmacists in all settings. (2024)
Presentation / Conference
TONNA, A. 2024. Antimicrobial stewardship: a potential role for pharmacists in all settings. Presented at 2024 European Society of Clinical Pharmacy (ESCP) CPD webinar, 06 February 2024, [virtual event].

The overall aim of the webinar is to familiarize participants with the potential role of pharmacists to support antimicrobial stewardship in different practice settings. After the webinar, participants should be able to a) to provide an overview of p... Read More about Antimicrobial stewardship: a potential role for pharmacists in all settings..